Suppr超能文献

基于链置换扩增-CRISPR/Cas12a扩增的双扩增单颗粒电感耦合等离子体质谱策略用于miRNA的均相检测

Dual-Amplification Single-Particle ICP-MS Strategy Based on Strand Displacement Amplification-CRISPR/Cas12a Amplification for Homogeneous Detection of miRNA.

作者信息

Xu Yan, Chen Beibei, He Man, Yuan Guolin, Hu Bin

机构信息

Department of Chemistry, Wuhan University, Wuhan 430072, China.

出版信息

Anal Chem. 2025 Jan 14;97(1):811-817. doi: 10.1021/acs.analchem.4c05385. Epub 2024 Dec 25.

Abstract

MicroRNAs (miRNAs) regulate a myriad of biological processes and thus have been regarded as useful biomarkers in biomedical research and clinical diagnosis. The specific and highly sensitive detection of miRNAs is of significant importance. Herein, a sensitive and rapid dual-amplification elemental labeling single-particle inductively coupled plasma-mass spectrometry (spICP-MS) analytical method based on strand displacement amplification (SDA) and CRISPR/Cas12a was developed for miRNA-21 detection. Taking gold nanoparticles (AuNPs) as the elemental labels, the Au NP probe initially hybridized with linker DNA, forming large aggregates. In the absence of target miRNA-21, large aggregates of AuNPs will produce high pulse signals in spICP-MS detection. In the presence of the target miRNA-21, it triggered the SDA reaction, and the SDA products activated CRISPR/Cas12a's trans-cleavage activity to cleave the linker DNA, resulting in disassembly of the AuNP aggregates. The AuNP aggregates with smaller size displayed lower pulse signals in spICP-MS detection. Under the optimal conditions, a good relationship between the average pulse signal intensity of AuNP aggregates and the concentration of miRNA-21 was obtained in the range of 0.5 fmol L-100 pmol L with a quantification limit as low as 0.5 fmol L. The developed method was successfully used for determination of miRNA-21 in human breast cancer cell lines (SK-BR-3 and MCF-7) and real blood samples from breast cancer patients. It is versatile, can be adapted to detect other targets by modifying the specific sequence of the SDA template chain that is complementary to the analytes, and offers a promising strategy for detecting various biomarkers with high sensitivity and specificity.

摘要

微小RNA(miRNA)调节众多生物过程,因此在生物医学研究和临床诊断中被视为有用的生物标志物。对miRNA进行特异性和高灵敏度检测具有重要意义。在此,基于链置换扩增(SDA)和CRISPR/Cas12a技术,开发了一种灵敏快速的双扩增元素标记单颗粒电感耦合等离子体质谱(spICP-MS)分析方法用于检测miRNA-21。以金纳米颗粒(AuNP)作为元素标记,AuNP探针最初与连接子DNA杂交,形成大聚集体。在没有目标miRNA-21的情况下,AuNP大聚集体在spICP-MS检测中会产生高脉冲信号。在有目标miRNA-21存在时,它触发SDA反应,SDA产物激活CRISPR/Cas12a的反式切割活性以切割连接子DNA,导致AuNP聚集体解体。尺寸较小的AuNP聚集体在spICP-MS检测中显示出较低的脉冲信号。在最佳条件下,AuNP聚集体的平均脉冲信号强度与miRNA-21浓度在0.5 fmol L-100 pmol L范围内呈现良好的关系,定量限低至0.5 fmol L。所开发的方法成功用于测定人乳腺癌细胞系(SK-BR-3和MCF-7)以及乳腺癌患者的实际血液样本中的miRNA-21。该方法具有通用性,通过修改与分析物互补的SDA模板链的特定序列可适用于检测其他目标,为高灵敏度和特异性检测各种生物标志物提供了一种有前景的策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验